Michael Tomsicek
DirectoratMilestone Pharmaceuticals· In proxies 2023–2025
Michael Tomsicek sits on 1 public board.
Experience
- Milestone PharmaceuticalsPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role -79%
- Acrivon Therapeutics, Inc. (Nasdaq: ACRV)Public company · 4 yr
- Director2022 – Present · 4 yrNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?